FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against MoonLake, a company listed on NASDAQ under the ticker MLTX, and has announced a deadline of December 15, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against the company [1]. Group 1 - Faruqi & Faruqi, LLP is a prominent national securities law firm with offices in New York, Pennsylvania, California, and Georgia [1].